Silva Francisco Insider Trades

Insider Trading History

Track insider trading activity for Silva Francisco. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
BioRestorative Therapies
BioRestorative Therapies BRTX
VP Of Research And Development
Holding Value $71k 171,384 shares
Last Trade
Oct 06, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$35.9k 23,438 shares
$1.53
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
VP Of Research And Development
Holding Value $319k 768,979 shares
Last Trade
Feb 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.89M 768,979 shares
$2.46
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
VP Of Research And Development
Holding Value $64.5k 155,759 shares
Last Trade
Apr 09, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.25k 6,600 shares
$1.25
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
VP Of Research And Development
Holding Value $61.8k 149,159 shares
Last Trade
Apr 08, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.98k 1,708 shares
$1.16
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
VP Of Research And Development
Holding Value $61.1k 147,451 shares
Last Trade
Mar 18, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$23.9k 17,193 shares
$1.39
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
10% owner, VP Of Research And Development
Holding Value $164k 394,737 shares
Last Trade
Feb 13, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$572k 394,737 shares
$1.45
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
10% owner, VP Of Research And Development
Holding Value $68.2k 164,644 shares
Last Trade
Aug 31, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11k 4,954 shares
$2.22
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
10% owner, VP Of Research And Development
Holding Value $66.2k 159,690 shares
Last Trade
Mar 31, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.66k 747 shares
$3.56
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
10% owner, VP Of Research And Development
Holding Value $65.9k 158,943 shares
Last Trade
Mar 20, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$19.6k 6,729 shares
$2.92
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
10% owner, VP Of Research And Development
Holding Value $68.6k 165,672 shares
Last Trade
Feb 18, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.12k 374 shares
$2.99
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
10% owner, VP Of Research And Development
Holding Value $44.2k 106,762 shares
Last Trade
Feb 17, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$311k 106,762 shares
$2.91
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
VP Of Research And Development
Holding Value $68.8k 166,046 shares
Last Trade
Nov 21, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.47k 943 shares
$2.62
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
VP Of Research And Development
Holding Value $0 0 shares
Last Trade
Nov 03, 2022 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$132k 42,059 shares
$3.15
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
VP Of Research And Development
Holding Value $122k 293,479 shares
Last Trade
Nov 03, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.06M 335,538 shares
$3.15
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
VP Of Research And Development
Holding Value $68.4k 165,103 shares
Last Trade
Oct 12, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.46k 725 shares
$3.39
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
VP Of Research And Development
Holding Value $68.1k 164,378 shares
Last Trade
Oct 11, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$2.97k 806 shares
$3.69
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
VP Of Research And Development
Holding Value $67.8k 163,572 shares
Last Trade
Aug 29, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$10.1k 3,123 shares
$3.22
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
VP Of Research And Development
Holding Value $66.6k 160,756 shares
Last Trade
Aug 26, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$8.71k 2,600 shares
$3.35
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
VP Of Research And Development
Holding Value $65.5k 158,156 shares
Last Trade
Aug 26, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$13.4k 3,958 shares
$3.39
$0.41
BioRestorative Therapies
BioRestorative Therapies BRTX
VP Of Research And Development
Holding Value $67.2k 162,114 shares
Last Trade
Jun 14, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$994 263 shares
$3.78
$0.41

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up